The Role of the Gastrointestinal Microbiota in Visceral Pain (Q46438777)

22 December 2017

title

The Role of the Gastrointestinal Microbiota in Visceral Pain (English)

1 reference

22 December 2017

author

Siobhain M O' Mahony

series ordinal

2

1 reference

22 December 2017

John F. Cryan

series ordinal

4

object named as

John F Cryan

1 reference

22 December 2017

3

Timothy G Dinan

1 reference

22 December 2017

author name string

Kieran Rea

series ordinal

1

1 reference

22 December 2017

publication date

30 December 2016

1 reference

22 December 2017

Handbook of experimental pharmacology

published in

1 reference

22 December 2017

volume

239

1 reference

22 December 2017

page(s)

269-287

1 reference

22 December 2017

A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.

cites work

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Commensal microbiota is fundamental for the development of inflammatory pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbiota, immune development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Ageing and gut microbes: perspectives for health maintenance and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The impact of microbiota on brain and behavior: mechanisms & therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbiota and neurodevelopmental windows: implications for brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Role of spinal cord glia in the central processing of peripheral pain perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Stool-based biomarkers of interstitial cystitis/bladder pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbiota regulation of the Mammalian gut-brain axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Review article: the economic impact of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbiota, enteroendocrine functions and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The tiny conductor: immune regulation via commensal organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The interplay between the intestinal microbiota and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbiota: Microbiota and neuroimmune signalling-Metchnikoff to microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

More than a gut feeling: the microbiota regulates neurodevelopment and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Role of intestinal bacteria in nutrient metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Crying in infants: on the possible role of intestinal microbiota in the development of colic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Collective unconscious: how gut microbes shape human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Immune responses to the microbiota at the intestinal mucosal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Immune modulation of the brain-gut-microbe axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Host microbiota constantly control maturation and function of microglia in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gastrointestinal microbiology enters the metagenomics era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Archaea and the human gut: new beginning of an old story.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The microbiota link to irritable bowel syndrome: an emerging story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Role of the gut microbiota in immunity and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Altered intestinal microbiota in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbial endocrinology and the microbiota-gut-brain axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbes and the brain: paradigm shift in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Brain-gut microbiome interactions and functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Imaging brain mechanisms in chronic visceral pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut/brain axis and the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The induction of pain: an integrative review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The microbiome: stress, health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Innate immune signalling at the intestinal epithelium in homeostasis and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The microbiome: A key regulator of stress and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Principles and clinical implications of the brain-gut-enteric microbiota axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Colonic bacterial metabolites and human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microglia: a newly discovered role in visceral hypersensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Antibiotics for irritable bowel syndrome: rationale and current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Control of brain development, function, and behavior by the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The human gut microbiota and virome: Potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microglia Function in Central Nervous System Development and Plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Intestinal microbiota in functional bowel disorders: a Rome foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Role of microbiome in regulating the HPA axis and its relevance to allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Microbial recognition by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Protease-activated receptors as drug targets in inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

Rodent Models of Colorectal Distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

The Essential Role of the Intestinal Microbiota in Facilitating Acute Inflammatory Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_115

21 January 2018

Identifiers

DOI

10.1007/164_2016_115

1 reference

22 December 2017

PubMed ID

28035535

1 reference

22 December 2017